ClinicalTrials.Veeva

Menu

Adductor Canal Block Versus Lumbar Plexus Block for Post Operative Pain Management After Total Knee Replacement

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

Pain Management

Treatments

Procedure: Ultrasound-guided Lumber Plexus Block
Procedure: adductor canal block

Study type

Interventional

Funder types

Other

Identifiers

NCT02853669
adductor canal

Details and patient eligibility

About

Adductor canal block (ACB), Saphenous nerve block, which is a block of a purely sensory nerve which shares in nerve supply of knee joint has a hypothetical advantage of better pain management with less motor affection. Also, it has a clear anatomical landmark that will increase the success rate (femoral artery) (*).On the other hand, being a branch of the femoral nerve and far distal from the plexus, this can decrease the blocking effectiveness. Likewise, the great variation of the knee nerve supply.

This prospective double-blinded randomized controlled trial is comparing ultrasound guided adductor canal block (ACB) versus ultrasound-guided lumbar plexus block (LPB) in patients undergoing total knee arthroplasty aiming at decreasing post-operative pain, helping in early mobilization and better physiotherapy.

This study hypothesizes that ACB, compared with LPB, will exhibit less motor, weakness, fewer opioids consumption with the same or better pain score.

Full description

This prospective double-blinded randomized controlled trial is comparing ultrasound guided adductor canal block (ACB) versus ultrasound-guided lumbar plexus block (LPB) in patients undergoing total knee arthroplasty aiming at decreasing post-operative pain, helping in early mobilization and better physiotherapy.

This study hypothesizes that ACB, compared with LPB, will exhibit less motor, weakness, fewer opioids consumption with the same or better pain score.

Enrollment

26 estimated patients

Sex

All

Ages

35 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA I-II
  • Age more than 25 and less than 80 were included

Exclusion criteria

  • Patients with known allergy to the medications to be given
  • ASA III, IV
  • Age less than 25 or more than 80
  • Dementia
  • Deafness
  • Psychological disease
  • Difficult to communicate
  • Cannot lay flat
  • INR more than 1.5
  • Low platelets (less than 100000/ml3) or with significant coagulopathy

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

26 participants in 2 patient groups

group (A) lumber plexus block
Experimental group
Description:
Ultrasound-guided Lumber plexus Block (30 cc of 0.25% of bupivacaine, via a 22-gauge 2-inch Stimuplex A needle) with nerve stimulator confirmation.
Treatment:
Procedure: Ultrasound-guided Lumber Plexus Block
Group (B) adductor canal block
Experimental group
Description:
ultrasound-guided Adductor Canal Block (15 cc of 0.5% of bupivacaine)
Treatment:
Procedure: adductor canal block

Trial contacts and locations

1

Loading...

Central trial contact

Hassan Ali, lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems